Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose for survival of ICU-admitted patients
IRCT20130829014521N22Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of trehalose in critical illness, sponsored by Mashhad University of Medical Sciences. Started Apr 2023; status: completed.
02
Drugs
trehalose
03
Conditions
critical illness
Beyond the preview
Go deeper on IRCT20130829014521N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130829014521N22.